直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Charitable

Breast Cancer Startup Challenge

March 5, 2014

Rockville, MD

National Institutes of Health

National Cancer Institute

The Avon Foundation

The Center for Advancing Innovation

Finnegan will support the Breast Cancer Startup Challenge, accelerating research and development innovation and commercialization for breast cancer-related inventions. The awards ceremony for the ten finalists will take place at the National Institutes of Health in Rockville, Maryland. For more information, please see the Breast Cancer Challenge event website.

Tags

startup

Related Insights

Articles

EPR Academy, Part 4 of 6: Choosing Between EPR, IPR, PGR, and Reissue

July 1, 2026

At the PTAB Blog

Deadline Evolution: Director Extends Deadline for Requesting Director Review of Institution Grants to 30 Days

June 30, 2026

At the PTAB Blog

New Informative Decision Applies the USPTO’s U.S. Manufacturing and Small Business Use of AIA Proceedings Memo

June 18, 2026

Lecture

Latest Developments in U.S. Section 337 Investigations and Response Strategies

June 12, 2026

Dongguan

Federal Circuit IP Blog

Federal Circuit Reinforces Injury-in-Fact Requirement in Appeals from Post-Grant Proceedings

June 10, 2026

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – June 2026

June 8, 2026

Articles

The Breakaway Problem: What USA Masters Weightlifting Got Wrong and What Every Splinter Group Should Know

May 29, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP